Fig. 1From: Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?Contribution of diabetes to pathophysiology of atrial fibrillation. OXPHOS oxidative phosphorylation, ATP adenosine triphosphate, ROS reactive oxygen species, CaMKII Ca2+/calmodulin dependent kinase II, AF atrial fibrillation. Part of illustration elements courtesy of Servier Medical ArtBack to article page